AE Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
2,468
+1,304
| +112% | +$580K | 0.01% | 699 |
|
|
2025
Q1 | $564K | Sell |
1,164
-1
| -0.1% | -$485 | ﹤0.01% | 881 |
|
|
2024
Q4 | $469K | Buy |
1,165
+29
| +3% | +$11.7K | ﹤0.01% | 934 |
|
|
2024
Q3 | $528K | Sell |
1,136
-31
| -3% | -$14.4K | ﹤0.01% | 873 |
|
|
2024
Q2 | $547K | Sell |
1,167
-166
| -12% | -$77.8K | 0.01% | 858 |
|
|
2024
Q1 | $557K | Sell |
1,333
-21,275
| -94% | -$8.89M | 0.01% | 788 |
|
|
2023
Q4 | $9.73M | Buy |
22,608
+1,710
| +8% | +$736K | 0.05% | 402 |
|
|
2023
Q3 | $7.27M | Buy |
20,898
+4,351
| +26% | +$1.51M | 0.04% | 449 |
|
|
2023
Q2 | $5.82M | Buy |
16,547
+14,732
| +812% | +$5.18M | 0.04% | 494 |
|
|
2023
Q1 | $572K | Sell |
1,815
-3,181
| -64% | -$1M | ﹤0.01% | 1282 |
|
|
2022
Q4 | $1.44M | Buy |
4,996
+3,552
| +246% | +$1.03M | 0.01% | 856 |
|
|
2022
Q3 | $418K | Buy |
1,444
+227
| +19% | +$65.7K | ﹤0.01% | 1345 |
|
|
2022
Q2 | $343K | Buy |
1,217
+271
| +29% | +$76.4K | ﹤0.01% | 1376 |
|
|
2022
Q1 | $247K | Buy |
+946
| New | +$247K | ﹤0.01% | 1500 |
|
|
2021
Q3 | – | Sell |
-1,027
| Closed | -$207K | – | 1688 |
|
|
2021
Q2 | $207K | Sell |
1,027
-11,804
| -92% | -$2.38M | ﹤0.01% | 1491 |
|
|
2021
Q1 | $2.76M | Buy |
12,831
+11,782
| +1,123% | +$2.53M | 0.03% | 481 |
|
|
2020
Q4 | $248K | Sell |
1,049
-3,355
| -76% | -$793K | ﹤0.01% | 1203 |
|
|
2020
Q3 | $1.2M | Buy |
4,404
+2,111
| +92% | +$574K | 0.02% | 582 |
|
|
2020
Q2 | $666K | Sell |
2,293
-1,795
| -44% | -$521K | 0.01% | 752 |
|
|
2020
Q1 | $973K | Buy |
4,088
+2,324
| +132% | +$553K | 0.02% | 493 |
|
|
2019
Q4 | $386K | Buy |
+1,764
| New | +$386K | 0.01% | 817 |
|